Evidence is mixed with support for and against the risk attributed to APOE*ε4 in the aetiology of depression.11–18 Conclusions are typically drawn from clinical studies with comparatively small sample sizes and that typically comprise vulnerable or at-risk populations, or larger population-based studies that are often cross-sectional or retrospective in design. The gene discussed is APOE; the disease is major depressive disorder.